Eastman Chemical Company (EMN)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Eastman Chemical Company.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 2 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. Scanners marked in red are red-flag signals (risk/short scanners) — appearing there is not a seal of approval. View all scanners
Trading Day
Key levels of the most recently completed trading day — not a live quote.
52-Week Range
Current price 72.00 $ — 62% of the range above the low.
Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 08/04/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
Quality & Screener
AAQS
5/10The AAQS (AlleAktien Quality Score) checks 10 quality criteria on growth, profitability, and balance-sheet strength — per the methodology developed and published by AlleAktien, calculated by us from our own fundamental data. A stock counts as a quality stock from 9 out of 10 points. Where a company has a shorter listing history, we calculate over the fiscal years available (at least five).
- Sales growth 10Y > 5% -0.2%
- Exp. sales growth 3Y > 5% 3.5%
- EBIT growth 10Y > 5% -5.5%
- Exp. EBIT growth 3Y > 5% 29.4%
- Net debt < 4x EBIT 4.8x
- EBIT positive, 10Y straight 10
- Max. EBIT decline < 50% 39.6%
- Return on equity > 15% 35.7%
- ROCE > 15% 7.6%
- Expected return > 10% 36.1%
View all AAQS quality stocks · Read the methodology at AlleAktien
Source: fundamental data
AI Rating
–Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built
Growth Score
2 of 10 Weak growthTen checks against the annual reports — each one passed counts a point.
- Revenue grows by more than 15% a year over three years -6.0% failed
- More than 10% revenue growth is expected for the coming year 2.6% failed
- Share count grows by less than 3% a year -2.6% passed
- Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") -1.9% failed
- Gross margin at 40% or higher and without meaningful erosion 21.1% failed
- Goodwill from acquisitions does not grow faster than revenue 24.7% failed
- Net debt below twice EBITDA 3.5 x EBITDA failed
- Operating cash flow covers the profits of the last three years 1,358 m passed
- Return on capital at 15% or higher, or up versus two years ago 7.6% failed
- Insiders hold at least 10% or are net buyers 0.9% failed
A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Analysts & Price Target
The price target sits 12.3% above the current price.
- Consensus
- Sell
- Analyst Ratings
- 15
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 6.31 | 5.85 – 6.80 | 9,243 | 16.4% | 12 |
| 12/31/2027 | 6.87 | 6.25 – 7.45 | 9,381 | 8.9% | 14 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | 2.80 | 7.20 | 2,245 | 1.80 | 14.70 | 540 | 365 |
| 2025: Q1 | 1.54 | 10.60 | 2,290 | -0.90 | 7.90 | -167 | -314 |
| 2025: Q2 | 1.20 | -37.90 | 2,287 | -3.20 | 6.10 | 233 | 83 |
| 2025: Q3 | 0.41 | -73.30 | 2,202 | -10.60 | 2.10 | 402 | 265 |
| 2025: Q4 | 0.91 | -67.40 | 1,973 | -12.10 | 5.30 | 502 | 390 |
| 2026: Q1 | 0.93 | -39.70 | 2,177 | -4.90 | 4.90 | -137 | -240 |
| 2026: Q2 | 1.59 | 32.50 | 2,513 | 9.90 | 7.30 | 224 | 124 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Annual Figures
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2016 | 8,945 | 1,542 | 866 | 5.84 | 1,385 | 4,545 | 15,457 |
| 2017 | 9,514 | 1,527 | 1,474 | 10.09 | 1,657 | 5,494 | 15,999 |
| 2018 | 10,122 | 1,473 | 1,080 | 7.56 | 1,543 | 5,803 | 15,995 |
| 2019 | 9,247 | 1,323 | 759 | 5.48 | 1,504 | 5,958 | 16,008 |
| 2020 | 8,464 | 1,125 | 478 | 3.50 | 1,455 | 6,023 | 16,083 |
| 2021 | 10,483 | 1,469 | 857 | 6.25 | 1,619 | 5,704 | 15,519 |
| 2022 | 10,535 | 1,084 | 793 | 6.35 | 975 | 5,153 | 14,667 |
| 2023 | 9,210 | 1,096 | 894 | 7.49 | 1,374 | 5,458 | 14,633 |
| 2024 | 9,382 | 1,376 | 905 | 7.68 | 1,287 | 5,779 | 15,213 |
| 2025 | 8,752 | 931 | 474 | 4.10 | 970 | 5,961 | 14,859 |
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
About the Company
Eastman Chemical Company ist ein Spezialmaterialunternehmen in den USA, China und international. Das Segment Additives & Functional Products bietet aminderivatbasierte Bausteine, Zwischenprodukte für Tenside, metambasierte Bodenfumigantien und organische säurebasierte Produkte an.
| Employees | 13,000 |
|---|---|
| Headquarters | Kingsport, TN |
| Address | 200 South Wilcox Drive, 37662 Kingsport, United States |
| Phone | 423 229 2000 |
| Website | eastman.com |
| IPO Date | 10. Oct 1993 |
| ISIN | US2774321002 |
| Stock Split | 2:1 on 10/04/2011 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Mark J. Costa | Chairman & CEO | 1966 |
| William Thomas McLain Jr. | CFO & Executive VP | 1973 |
| Brad A. Lich | Executive VP & Chief Commercial Officer | 1968 |
| B. Travis Smith | Executive VP of Additives & Functional Products, Manufacturing, WWE&C and HSE | 1974 |
| Michelle R. Stewart | VP, Chief Accounting Officer & Controller | 1972 |
| Stephen Glenn Crawford | EVP, CTO & Chief Sustainability Officer | 1965 |
| Gregory A. Riddle | Vice President of Investor Relations & Communications | 1969 |
| Ike Adeyemi | Senior VP, Chief Legal Officer & Corporate Secretary | 1978 |
| Adrian J. Holt | Senior VP & Chief Human Resources Officer | 1969 |
| J. P. Kuijpers | MD of EMEA Region & Global Procurement Director | – |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Chart
Interactive price chart (TradingView).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.